Novo’s newest GLP-1, CagriSema, is the first big test of Novo Nordisk’s future as the leader in the obesity treatment market.

She's going to have good arms!' I was ten years old and standing in my parents' bathroom when I heard my mother say this.

In emotional scenes, the former OnlyFans model, 27, couldn't keep it together as she candidly told her co-stars that her 2022 ...

Olivia Julianna, a Houston activist and social media personality, quelled all rumors that she had gone on a hunger strike in ...

Comedian Amy Schumer revealed that, while she had success using the popular weight loss drug Ozempic, she had to quit taking it due to the side effects.

Novo Nordisk sells the drug semaglutide under the brands Ozempic for diabetes and Wegovy ... hit the market as Mounjaro for diabetes until 2022 and Zepbpund for weight loss until 2023, the study ...

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks ...

Amy Schumer once hopped on board the Ozempic trend, but the side effects were so intense she had to stop. During a recent appearance on "The Howard Stern Show," the comedian, 43, opened up about ...

Weight-loss drugs such as Ozempic have been a breakthrough because they eliminate the need to cut back or compensate by mimicking the gut hormone (GLP-1) and making people feel full faster.

Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent studies highlight side effects such as heart muscle weakening and skin ...

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like nausea and diarrhea. But new research confirms that more serious ...

Do a quick Google search for berberine and you will come across a handful of interesting headlines referring to it as “nature’s Ozempic.” And considering the rising popularity of Ozempic and ...